The Thoracic and Cardiovascular Surgeon, Table of Contents Thorac Cardiovasc Surg 2004; 52(1): 29-33DOI: 10.1055/s-2004-817799 Original Cardiovascular © Georg Thieme Verlag Stuttgart · New YorkPerfusion Temperature During Cardiopulmonary Bypass Does not Affect Serum S-100β ReleaseM. Dworschak 1 , A. Lassnigg 1 , G. Tenze 1 , D. Zimpfer 2 , M. Czerny 2 , M. Grimm 2 , R. Schmid 3 , G. Grubhofer 1 1Department of Cardiothoracic and Vascular Anesthesia and Intensive Care, General Hospital Vienna, Austria 2Department of Cardiovascular Surgery, General Hospital Vienna, Austria 3Institute of Medical and Chemical Laboratory Diagnostics, General Hospital Vienna, Austria Recommend Article Abstract Buy Article(opens in new window) All articles of this category(opens in new window) Abstract Background: The potentially harmful effects of normothermia on neurological outcome during cardiopulmonary bypass (CPB) are controversial. Methods: In this study, we compared the early and late release patterns of S-100β, a marker of cerebral injury, after normothermic and moderately hypothermic CPB. Forty-eight patients undergoing coronary artery bypass grafting were randomly assigned to either the normothermia (37 °C) or the hypothermia (32 °C) group. Serum S-100β levels were measured until 24 h after CPB. Neurological examination was performed before and after surgery. Results: With the exception of intraoperative blood glucose levels, there were no differences between groups. This also applied to peak S-100β values (Gr-N: 3.5 ± 1.9 µg/l; Gr-H: 3.5 ± 3.4 µg/l) and values after 24 h (Gr-N: 0.32 ± 0.16 µg/l; Gr-H: 0.35 ± 0.28 µg/l). Conclusions: The similar pattern of S-100β release without evident neurological complications in the normothermia group does not suggest an increase in cerebral injury during normothermic CPB. Key words Cardiopulmonary bypass - normothermia - brain injury - biochemical markers - S-100β Full Text References References 1 The Warm Heart Investigators . Randomised trial of normothermic versus hypothermic coronary bypass surgery. Lancet. 1994; 343 559-563 2 Mora C T, Henson M B, Weintraub W S. et al . The effect of temperature management during cardiopulmonary bypass on neurological and neuropsychologic outcomes in patients undergoing coronary revascularization. J Thorac Cardiovasc Surg. 1996; 112 514-522 3 Martin T D, Craver J M, Gott J P. et al . Prospective, randomized trial of retrograde warm blood cardioplegia: myocardial benefit and neurological threat. Ann Thorac Surg. 1994; 57 298-302 4 Singh A K, Feng W C, Bert A A, Rotenberg F A. Warm body, cold heart surgery. Clinical experience in 2817 patients. Eur J Cardiothorac Surg. 1993; 7 225-229 5 Christenson J T, Maurice J, Simonet F, Velebit V, Schmuziger M. Normothermic versus hypothermic perfusion during primary coronary artery bypass grafting. Cardiovasc Surg. 1995; 3 519-524 6 Craver J M, Bufkin B L, Weintraub W S, Guyton R A. Neurological events after coronary bypass grafting: further observations with warm cardioplegia. Ann Thorac Surg. 1995; 59 1429-1433 7 Ali M S, Harmer M, Vaughan R. Serum S100 protein as a marker of cerebral damage during cardiac surgery. Br J Anaesth. 2000; 85 287-298 8 Taggart D P, Bhattacharya K, Meston N. et al . Serum S-100 protein concentration after cardiac surgery: a randomized trial of arterial line filtration. Eur J Cardiothor Surg. 1997; 11 645-649 9 Westaby S, Johnsson P, Parry A J. et al . Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass. Ann Thorac Surg. 1996; 6 88-92 10 Beaudeux J L, Leger P, Dequen L. et al . Influence of hemolysis on the measurement of S-100 beta protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting. Clin Chem. 2000; 46 989-990 11 Abraha H D, Butterworth R J, Bath P M. et al . Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem. 1997; 34 366-370 12 Georgiadis D, Berger A, Kowatschev E. et al . Predictive value of S-100 beta and neuron-specific enolase serum levels for adverse neurological outcome after cardiac surgery. J Thorac Cardiovasc Surg. 2000; 119 138-147 13 Kilminster S, Treasure T, McMillan T, Holt D W. Neuropsychological change and S-100 protein release in 130 unselected patients undergoing cardiac surgery. Stroke. 1999; 30 1869-1874 14 Vanninen R, Aikiä M, Könönen M. et al . Subclinical cerebral complications after coronary artery bypass grafting: prospective analysis with magnetic resonance imaging, quantitative electroencephalography, and neuropsychological assessment. Arch Neurol. 1998; 55 618-627 15 Jönsson H, Johnsson P, Alling C. et al . S100beta after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg. 1999; 68 2202-2208 16 Herrmann M, Ebert A D, Galazky I. et al . Neurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue. Stroke. 2000; 31 645-650 17 Jönsson H, Johnsson P, Alling C. et al . Significance of serum S100 release after coronary artery bypass grafting. Ann Thorac Surg. 1998; 65 1639-1644 18 Grimm M, Czerny M, Baumer H. et al . Normothermic cardiopulmonary bypass is beneficial for cognitive brain function after coronary artery bypass grafting - a prospective randomized trial. Eur J Cardiothorac Surg. 2000; 18 270-275 19 Blauth C I. Macroemboli and microemboli during cardiopulmonary bypass. Ann Thorac Surg. 1995; 59 1300-1303 20 Mills S A. Risk factors for cerebral injury and cardiac surgery. Ann Thorac Surg. 1995; 59 1296-1299 21 Grocott H P, Croughwell N D, Amory D W. et al . Cerebral emboli and serum S100beta during cardiac operations. Ann Thorac Surg. 1998; 65 1645-1649 Dr. M. D. Martin Dworschak Department of Cardiothoracic and Vascular Anesthesia and Intensive Care, University Clinic of Anesthesia Waehringer Guertel 18 - 20 1090 Vienna Austria Phone: + 431404004109 Fax: + 43 14 04 00 41 10 Email: martin.dworschak@univie.ac.at